CAPR has been in the news 333% more than usual
Aug 23, 2025, 2:32 PM
-5.20%
What does CAPR do
Capricor Therapeutics, based in Beverly Hills, develops biological therapies for serious medical conditions, focusing on CAP-1002 for Duchenne muscular dystrophy in Phase 3 trials. The company also utilizes exosome technology for various therapeutic applications.
CAPR has been in the news recently: Capricor Therapeutics is facing multiple class action lawsuits for allegedly misleading statements and securities fraud related to its operations between October 9, 2024, and July 10, 2025. Investors have a deadline of September 15, 2025, to act as lead plaintiffs in these lawsuits.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.